Loading...
Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial
Familial dysbetalipoproteinemia (FD) is a genetic disorder associated with impaired postprandial lipid clearance. The effect of adding bezafibrate to standard lipid-lowering therapy on postprandial and fasting lipid levels in patients with FD is unknown. In this randomized placebo-controlled double-...
Na minha lista:
| Udgivet i: | J Lipid Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Biochemistry and Molecular Biology
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5665665/ https://ncbi.nlm.nih.gov/pubmed/28928170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M076901 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|